Dutch Study Confirms That Covid-19 In Pregnant Women Can Lead To Stillbirths

A Dutch study suggests that pregnant women infected with the coronavirus can experience severe complications in the second half of their pregnancy that result in stillbirths. It's important therefore to implement Covid-19 prevention strategies, including vaccination before or during pregnancy.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation Leadership /leadership ForbesWomen /forbeswomen Editors' Pick editors-pick Coronavirus business pharma & Source Type: news

Related Links:

Rachel, 38, said she was discouraged from having the Covid vaccine in the early days of the rolloutCoronavirus – latest updatesSee all our coronavirus coverageA mother whose baby was stillborn while she was in hospital withCovid-19 has urged people to get vaccinated to save themselves the “agony” of becoming seriously ill with the virus.Rachel, 38, from Bilston in Wolverhampton, who did not wish to use her surname, was so unwell she did not realise she had given birth to her son Jaxon, at 24 weeks, in August, and was in a coma and in hospital for three and a half months after contracting the virus.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Pregnancy Coronavirus Vaccines and immunisation UK news Infectious diseases Health Science Source Type: news
In Scotland, as in the United States, vaccination rates of pregnant women are low, even though there is no evidence that the Pfizer-BioNTech or Moderna vaccines pose serious risks during pregnancy.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Pregnancy and Childbirth Coronavirus (2019-nCoV) Babies and Infants Vaccination and Immunization Source Type: news
The COVID era has brought us many new experiences: mask-wearing, remote schooling, sheltering in place. The majority of these have been onerous and dreary. It’s amazing how energy-sapping it is to just have to wait for something to be over. But now at last we can do a new activity! An activity that will help reduce the spread of COVID! An activity that takes us places we haven’t been before, from the comfort of our home! And that activity is sticking a swab up our noses and investigating what comes out. Testing for COVID at home, I would argue, is the project we’ve all been waiting for. It’s good f...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Source Type: news
Coronavirus (COVID-19) vaccination information for public health professionals. 12 January 2022Updated background to include latest data on vaccine effectiveness and booster safety; clarified and corrected chronology of booster advice. Clarified clinical advice about vaccination of 5 to 11 year olds at high risk: interchangeability of adult, fractional and paediatric doses; management of 5 to 11s who are about to become immunosuppressed; advice on third primary doses for severe immunosuppression, including updated definitions for severe immunosuppression for younger children. 24 December 2021Updated to include JCVI adv...
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
The government ’s campaign promoting boosters to those who are pregnant is vital, but it should have been done months agoViki Male is a lecturer in reproductive immunology at Imperial College LondonWhen you ’re pregnant, it’s understandable that you might feel cautious. After all, you’re told to avoid all sorts of things – soft cheeses, alcohol, certain medications – because they could be bad for the baby. You might find it surprising to be recommended a medical treatment that is still quite new.This partly explains why levels of Covid vaccination during pregnancy still seem to be relati...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Pregnancy Vaccines and immunisation Coronavirus Health UK news Science Source Type: news
NEW BRUNSWICK, N.J., January 6, 2022 – Johnson &Johnson (NYSE: JNJ) (the Company) today announced new results from the largest study to date on the durability of COVID-19 vaccines in the United States (U.S.), showing that a single shot of the Johnson &Johnson COVID-19 vaccine resulted in long-lasting protection for up to six months against COVID-19 breakthrough infections, hospitalizations, and intensive care unit (ICU) admissions. The study was sponsored by the Janssen Pharmaceutical Companies of Johnson &Johnson and conducted in partnership with the Department of Science-Aetion, Inc, and the Division of...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
There’s yet another colorful addition to the pandemic lexicon—“flurona”—but it doesn’t refer to a new variant or even a new condition. The made-up term describes simultaneous infection with both influenza and SARS-CoV-2, the virus that causes COVID-19. The two diseases do not combine to make some hybrid form of either virus, which makes “flurona” a bit of a fearmongering misnomer. But co-infection is becoming more common. Having COVID-19 and the flu at the same time has been a possibility since the beginning of the pandemic, but until now, rigorous safety precautions largely ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
This report describes how COVID-19 vaccination during pregnancy was not associated with preterm or small-for-gestational-age at birth compared with unvaccinated pregnant women.
Source: CDC Morbidity and Mortality Weekly Report - Category: American Health Tags: Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report Pre-term Births Pregnancy Vaccination Women's Health COVID-19 Pregnancy-Related Complications Source Type: news
Women who were vaccinated while pregnant were at no greater risk of delivering prematurely, nor of having small babies.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Coronavirus (2019-nCoV) Vaccination and Immunization Pregnancy and Childbirth Coronavirus Risks and Safety Concerns Premature Babies Women and Girls Centers for Disease Control and Prevention Harvard Pilgrim Health Care Kaiser Permanente Source Type: news
NEW BRUNSWICK, N.J., December 30, 2021 – Johnson &Johnson (NYSE: JNJ) (the Company) today announced new preliminary results from the South African Phase 3b Sisonke study which showed that a homologous (same vaccine) booster shot of the Johnson &Johnson COVID-19 vaccine (Ad26.COV2.S) demonstrated 85 percent effectiveness against COVID-19-related hospitalization. The study, conducted by the South African Medical Research Council (SAMRC), showed that the Johnson &Johnson booster reduced the risk of hospitalization from COVID-19 among healthcare workers in South Africa after Omicron became the dominant varian...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
More News: Coronavirus | COVID-19 | Netherlands Health | Pharmaceuticals | Pregnancy | Study | Vaccines | Women